Saturday, April 2, 2022

Other news to note for April 1, 2022 | BioWorld

Cell and gene therapy firm Abeona Therapeutics Inc., of New York, will focus its resources on the phase III VIITAL study of EB-101 for recessive ...
https://www.google.com/url?rct=j&sa=t&url=https://www.bioworld.com/articles/517472-other-news-to-note-for-april-1-2022&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNEQP5Std_Zu9Y3aMtKk3KMwZSSgYA

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...